Response rate in patients with WR-NKTL
| . | Total, no. . | CR, no. (%) . | PR, no. (%) . | SD, no. (%) . | PD, no. (%) . |
|---|---|---|---|---|---|
| All patients, n = 91 | |||||
| Response after initial therapy | |||||
| RT | 31 | 24 (77) | 6 (19) | 0 (0) | 1 (3) |
| CT | 60 | 18 (30) | 37 (62) | 5 (8) | 0 (0) |
| Response after therapy | |||||
| RT alone | 13 | 10 (77) | 3 (23) | 0 (0) | 0 (0) |
| RT + CT | 18 | 16 (89) | 1 (6) | 0 (0) | 1 (6) |
| CT + RT ± CT | 46 | 39 (85) | 6 (13) | 0 (0) | 1 (2) |
| CT alone | 14 | 7 (50) | 6 (43) | 1 (7) | 0 (0) |
| Total | 91 | 72 (79) | 16 (18) | 1 (1) | 2 (2) |
| Stages I and II, n = 71 | |||||
| Response after initial therapy | |||||
| RT | 31 | 24 (77) | 6 (19) | 0 (0) | 1 (3) |
| CT | 40 | 9 (23) | 26 (65) | 5 (13) | 0 (0) |
| Response after therapy | |||||
| RT alone | 13 | 10 (77) | 3 (23) | 0 (0) | 0 |
| RT + CT | 18 | 16 (89) | 1 (6) | 0 (0) | 1 (6) |
| CT + RT ± CT | 36 | 30 (83) | 5 (14) | 0 (0) | 1 (3) |
| CT alone | 4 | 1 (25) | 2 (50) | 1 (25) | 0 (0) |
| Total | 71 | 57 (80) | 11 (15) | 1 (1) | 2 (3) |
| . | Total, no. . | CR, no. (%) . | PR, no. (%) . | SD, no. (%) . | PD, no. (%) . |
|---|---|---|---|---|---|
| All patients, n = 91 | |||||
| Response after initial therapy | |||||
| RT | 31 | 24 (77) | 6 (19) | 0 (0) | 1 (3) |
| CT | 60 | 18 (30) | 37 (62) | 5 (8) | 0 (0) |
| Response after therapy | |||||
| RT alone | 13 | 10 (77) | 3 (23) | 0 (0) | 0 (0) |
| RT + CT | 18 | 16 (89) | 1 (6) | 0 (0) | 1 (6) |
| CT + RT ± CT | 46 | 39 (85) | 6 (13) | 0 (0) | 1 (2) |
| CT alone | 14 | 7 (50) | 6 (43) | 1 (7) | 0 (0) |
| Total | 91 | 72 (79) | 16 (18) | 1 (1) | 2 (2) |
| Stages I and II, n = 71 | |||||
| Response after initial therapy | |||||
| RT | 31 | 24 (77) | 6 (19) | 0 (0) | 1 (3) |
| CT | 40 | 9 (23) | 26 (65) | 5 (13) | 0 (0) |
| Response after therapy | |||||
| RT alone | 13 | 10 (77) | 3 (23) | 0 (0) | 0 |
| RT + CT | 18 | 16 (89) | 1 (6) | 0 (0) | 1 (6) |
| CT + RT ± CT | 36 | 30 (83) | 5 (14) | 0 (0) | 1 (3) |
| CT alone | 4 | 1 (25) | 2 (50) | 1 (25) | 0 (0) |
| Total | 71 | 57 (80) | 11 (15) | 1 (1) | 2 (3) |
WR-NKTL indicates nasal-type NK/T-cell lymphoma of Waldeyer ring; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; RT, radiotherapy; and CT, chemotherapy.